Related references
Note: Only part of the references are listed.A Randomized Clinical Trial of the Immunogenicity of 7-Valent Pneumococcal Conjugate Vaccine Compared to 23-Valent Polysaccharide Vaccine in Frail, Hospitalized Elderly
C. Raina MacIntyre et al.
PLOS ONE (2014)
Profiling human antibody responses by integrated single-cell analysis
Adebola O. Ogunniyi et al.
VACCINE (2014)
Sequential administration of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults 60-64 years of age
Richard N. Greenberg et al.
VACCINE (2014)
Safety and immunogenicity of 13-valent pneumococcal conjugate vaccine formulations with and without aluminum phosphate and comparison of the formulation of choice with 23-valent pneumococcal polysaccharide vaccine in elderly adults A randomized open-label trial
Christine Juergens et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)
Fully human monoclonal antibodies from antibody secreting cells after vaccination with Pneumovax®23 are serotype specific and facilitate opsonophagocytosis
Kenneth Smith et al.
IMMUNOBIOLOGY (2013)
Optimization of a human IgG B-cell ELISpot assay for the analysis of vaccine-induced B-cell responses
Maja Jahnmatz et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2013)
Lineage Structure of the Human Antibody Repertoire in Response to Influenza Vaccination
Ning Jiang et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Influence of initial vaccination with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine on anti-pneumococcal responses following subsequent pneumococcal vaccination in adults 50 years and older
Lisa A. Jackson et al.
VACCINE (2013)
Pneumococcal polysaccharide vaccination induces polysaccharide-specific B cells in adult peripheral blood expressing CD19+CD20+CD3-CD70-CD27+IgM+CD43+CD5+/-
David J. Leggat et al.
VACCINE (2013)
Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccine
Lisa A. Jackson et al.
VACCINE (2013)
Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults
Lisa A. Jackson et al.
VACCINE (2013)
Pneumococcal Conjugate and Plain Polysaccharide Vaccines Have Divergent Effects on Antigen-Specific B Cells
Elizabeth A. Clutterbuck et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Polyfunctional responses by human T cells result from sequential release of cytokines
Qing Han et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Development and Optimization of a Process for Automated Recovery of Single Cells Identified by Microengraving
Jae Hyeok Choi et al.
BIOTECHNOLOGY PROGRESS (2010)
Safety and Antibody Response, Including Antibody Persistence for 5 Years, after Primary Vaccination or Revaccination with Pneumococcal Polysaccharide Vaccine in Middle-Aged and Older Adults
Daniel M. Musher et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Multidimensional analysis of the frequencies and rates of cytokine secretion from single cells by quantitative microengraving
Qing Han et al.
LAB ON A CHIP (2010)
The early kinetics of circulating pneumococcal-specific memory B cells following pneumococcal conjugate and plain polysaccharide vaccines in the elderly
Helen E. Baxendale et al.
VACCINE (2010)
Efficacy of pneumococcal vaccination in adults: a meta-analysis
Anke Huss et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2009)
Clonal dissection of the human memory B-cell repertoire following infection and vaccination
Debora Pinna et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
Screening individual hybridomas by microengraving to discover monoclonal antibodies
Adebola O. Ogunniyi et al.
NATURE PROTOCOLS (2009)
Concurrent detection of secreted products from human lymphocytes by microengraving: Cytokines and antigen-reactive antibodies
Elizabeth M. Bradshaw et al.
CLINICAL IMMUNOLOGY (2008)
Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults:: Conjugate vaccine elicits improved antibacterial immune responses and immunological memory
Andres de Roux et al.
CLINICAL INFECTIOUS DISEASES (2008)
Rapid cloning of high-affinity human monoclonal antibodies against influenza virus
Jens Wrammert et al.
NATURE (2008)
Profiling antibody responses by multiparametric analysis of primary B cells
Craig M. Story et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
A microengraving method for rapid selection of single cells producing antigen-specific antibodies
J. Christopher Love et al.
NATURE BIOTECHNOLOGY (2006)
The current burden of pneumococcal disease in England and Wales
A Melegaro et al.
JOURNAL OF INFECTION (2006)
Human blood IgM memory B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire
S Weller et al.
BLOOD (2004)
Revaccination with the 23-valent pneumococcal polysaccharide vaccine in middle-aged and elderly persons previously treated for pneumonia
J Törling et al.
VACCINE (2003)
Recurrent variable region gene usage and somatic mutation in the human antibody response to the capsular polysaccharide of Streptococcus pneumoniae type 23F
JH Zhou et al.
INFECTION AND IMMUNITY (2002)
Human immunoglobulin variable region gene analysis by single cell RT-PCR
XW Wang et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2000)
Share Paper
